278 related articles for article (PubMed ID: 11252686)
1. Celecoxib versus diclofenac in the management of osteoarthritis of the knee.
McKenna F; Borenstein D; Wendt H; Wallemark C; Lefkowith JB; Geis GS
Scand J Rheumatol; 2001; 30(1):11-8. PubMed ID: 11252686
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and tolerability of lumiracoxib 100 mg once daily in knee osteoarthritis: a 13-week, randomized, double-blind study vs. placebo and celecoxib.
Lehmann R; Brzosko M; Kopsa P; Nischik R; Kreisse A; Thurston H; Litschig S; Sloan VS
Curr Med Res Opin; 2005 Apr; 21(4):517-26. PubMed ID: 15899100
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and tolerability of lumiracoxib in the treatment of osteoarthritis of the knee: a 13-week, randomized, double-blind comparison with celecoxib and placebo.
Sheldon E; Beaulieu A; Paster Z; Dutta D; Yu S; Sloan VS
Clin Ther; 2005 Jan; 27(1):64-77. PubMed ID: 15763607
[TBL] [Abstract][Full Text] [Related]
4. Lumiracoxib is effective in the treatment of osteoarthritis of the knee: a prospective randomized 13-week study versus placebo and celecoxib.
Fleischmann R; Sheldon E; Maldonado-Cocco J; Dutta D; Yu S; Sloan VS
Clin Rheumatol; 2006 Feb; 25(1):42-53. PubMed ID: 16132165
[TBL] [Abstract][Full Text] [Related]
5. Lumiracoxib is effective in the treatment of osteoarthritis of the knee: a 13 week, randomised, double blind study versus placebo and celecoxib.
Tannenbaum H; Berenbaum F; Reginster JY; Zacher J; Robinson J; Poor G; Bliddal H; Uebelhart D; Adami S; Navarro F; Lee A; Moore A; Gimona A
Ann Rheum Dis; 2004 Nov; 63(11):1419-26. PubMed ID: 15020310
[TBL] [Abstract][Full Text] [Related]
6. A randomized, multicentre, double-blind, parallel-group study to assess the adverse event-related discontinuation rate with celecoxib and diclofenac in elderly patients with osteoarthritis.
Dahlberg LE; Holme I; Høye K; Ringertz B
Scand J Rheumatol; 2009; 38(2):133-43. PubMed ID: 19165648
[TBL] [Abstract][Full Text] [Related]
7. First-dose analgesic effect of the cyclo-oxygenase-2 selective inhibitor lumiracoxib in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled comparison with celecoxib [NCT00267215].
Wittenberg RH; Schell E; Krehan G; Maeumbaed R; Runge H; Schlüter P; Fashola TO; Thurston HJ; Burger KJ; Trechsel U
Arthritis Res Ther; 2006; 8(2):R35. PubMed ID: 16469112
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of epicutaneous ketoprofen in Transfersome (IDEA-033) versus oral celecoxib and placebo in osteoarthritis of the knee: multicentre randomised controlled trial.
Rother M; Lavins BJ; Kneer W; Lehnhardt K; Seidel EJ; Mazgareanu S
Ann Rheum Dis; 2007 Sep; 66(9):1178-83. PubMed ID: 17363401
[TBL] [Abstract][Full Text] [Related]
9. S-adenosyl methionine (SAMe) versus celecoxib for the treatment of osteoarthritis symptoms: a double-blind cross-over trial. [ISRCTN36233495].
Najm WI; Reinsch S; Hoehler F; Tobis JS; Harvey PW
BMC Musculoskelet Disord; 2004 Feb; 5():6. PubMed ID: 15102339
[TBL] [Abstract][Full Text] [Related]
10. Analgesic effectiveness of celecoxib and diclofenac in patients with osteoarthritis of the hip requiring joint replacement surgery: a 12-week, multicenter, randomized, double-blind, parallel-group, double-dummy, noninferiority study.
Emery P; Koncz T; Pan S; Lowry S
Clin Ther; 2008 Jan; 30(1):70-83. PubMed ID: 18343244
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the effectiveness and tolerability of lidocaine patch 5% versus celecoxib for osteoarthritis-related knee pain: post hoc analysis of a 12 week, prospective, randomized, active-controlled, open-label, parallel-group trial in adults.
Kivitz A; Fairfax M; Sheldon EA; Xiang Q; Jones BA; Gammaitoni AR; Gould EM
Clin Ther; 2008 Dec; 30(12):2366-77. PubMed ID: 19167595
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of celecoxib versus ibuprofen for the treatment of patients with osteoarthritis of the knee: A randomized double-blind, non-inferiority trial.
Gordo AC; Walker C; Armada B; Zhou D
J Int Med Res; 2017 Feb; 45(1):59-74. PubMed ID: 28222627
[TBL] [Abstract][Full Text] [Related]
13. Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I Study.
Singh G; Fort JG; Goldstein JL; Levy RA; Hanrahan PS; Bello AE; Andrade-Ortega L; Wallemark C; Agrawal NM; Eisen GM; Stenson WF; Triadafilopoulos G;
Am J Med; 2006 Mar; 119(3):255-66. PubMed ID: 16490472
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of celecoxib in treating symptoms of viral pharyngitis: a double-blind, randomized study of celecoxib versus diclofenac.
Weckx LL; Ruiz JE; Duperly J; Mendizabal GA; Rausis MB; Piltcher SL; Saffer M; Matsuyama C; Levy S; Fort JG
J Int Med Res; 2002; 30(2):185-94. PubMed ID: 12025527
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of nonsteroidal anti-inflammatory drugs in Asian patients with knee osteoarthritis: summary of a randomized, placebo-controlled study.
Essex MN; O'Connell MA; Behar R; Bao W
Int J Rheum Dis; 2016 Mar; 19(3):262-70. PubMed ID: 25990559
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of rofecoxib, celecoxib, and acetaminophen in osteoarthritis of the knee: a randomized trial.
Geba GP; Weaver AL; Polis AB; Dixon ME; Schnitzer TJ;
JAMA; 2002 Jan; 287(1):64-71. PubMed ID: 11754710
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of rofecoxib, celecoxib, and acetaminophen in patients with osteoarthritis of the knee. A combined analysis of the VACT studies.
Schnitzer TJ; Weaver AL; Polis AB; Petruschke RA; Geba GP;
J Rheumatol; 2005 Jun; 32(6):1093-105. PubMed ID: 15940774
[TBL] [Abstract][Full Text] [Related]
18. A multicentre, randomized, placebo- and active-controlled trial comparing the efficacy and safety of topical ketoprofen in Transfersome gel (IDEA-033) with ketoprofen-free vehicle (TDT 064) and oral celecoxib for knee pain associated with osteoarthritis.
Conaghan PG; Dickson J; Bolten W; Cevc G; Rother M
Rheumatology (Oxford); 2013 Jul; 52(7):1303-12. PubMed ID: 23542612
[TBL] [Abstract][Full Text] [Related]
19. Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison.
Emery P; Zeidler H; Kvien TK; Guslandi M; Naudin R; Stead H; Verburg KM; Isakson PC; Hubbard RC; Geis GS
Lancet; 1999 Dec 18-25; 354(9196):2106-11. PubMed ID: 10609815
[TBL] [Abstract][Full Text] [Related]
20. Celecoxib improves the efficiency of the locomotor mechanism in patients with knee osteoarthritis. A randomised, placebo, double-blind and cross-over trial.
Detrembleur C; De Nayer J; van den Hecke A
Osteoarthritis Cartilage; 2005 Mar; 13(3):206-10. PubMed ID: 15727886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
